Market revenue in 2023 | USD 61.4 million |
Market revenue in 2030 | USD 101.4 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Ultrasound |
Fastest growing segment | PAMG-1 Immunoassay |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN) |
Key market players worldwide | Qiagen NV, Hologic Inc, CooperSurgical, Abbott Laboratories, Biosynex, Sera Prognostics, Medix Biochemica, Clinical Innovations, NX Prenatal, IQ Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preterm birth and prom testing market will help companies and investors design strategic landscapes.
Ultrasound was the largest segment with a revenue share of 31.11% in 2023. Horizon Databook has segmented the Middle East & Africa preterm birth and prom testing market based on pelvic exam, ultrasound, biochemical markers, uterine monitoring, nitazine test, ferning test, pooling, pamg-1 immunoassay, igfbp test, fetal fibronectin (ffn) covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Middle East and Africa preterm birth and PROM testing market can be attributed to continuous government initiatives to increase access to innovative preterm birth and PROM testing solutions in the region.
Furthermore, increasing risk of preterm birth and PROM due to high prevalence of maternal malnutrition, infectious diseases, unhealthy living conditions, and smoking in African countries is expected to create high demand for preterm birth and PROM testing solutions.
However, uncertain reimbursement scenarios, weak healthcare infrastructure, and low affordability of expensive tests in some countries of MEA region are expected to be a major threat to the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa preterm birth and prom testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa preterm birth and prom testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account